Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Januvia added to metformin in type 2 diabetes mellitus
NCT00337610Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Jun 2006; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00337610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337610.